Skeletal Muscle Composition Predicts Outcome in Critically Ill Patients.

biomarker cachexia intensive care unit prognosis sarcopenia

Journal

Critical care explorations
ISSN: 2639-8028
Titre abrégé: Crit Care Explor
Pays: United States
ID NLM: 101746347

Informations de publication

Date de publication:
Aug 2020
Historique:
entrez: 25 8 2020
pubmed: 25 8 2020
medline: 25 8 2020
Statut: epublish

Résumé

Parameters of patients' body composition have been suggested as prognostic markers in several clinical conditions including cancer and liver transplantation, but only limited data on its value in critical illness exist to date. In this study, we aimed at evaluating a potential prognostic value of the skeletal muscle mass and skeletal muscle myosteatosis of critically ill patients at admission to the ICU. Exploratory observational cohort study. An urban, academic medical institution. One-hundred fifty-five patients treated for critical illness on a medical ICU. None. We used routine CT scans to assess the patients' individual body composition. The skeletal muscle index as a surrogate for sarcopenia was defined as the total skeletal muscle area at the level of the third lumbar vertebra on axial CT scan, normalized for the patient's height. Myosteatosis was evaluated by assessing the mean skeletal muscle attenuation measured in Hounsfield unit at the same sectional plane. The skeletal muscle index and mean skeletal muscle attenuation at admission to the ICU were significantly higher in patients with long-term survival (180-day or 1-year mortality), while both parameters were comparable between short-term survivors and nonsurvivors (ICU mortality or 30-d mortality). Patients with a skeletal muscle index or mean skeletal muscle attenuation below our established ideal cutoff values (74.95 mm Our data suggest that sarcopenia and myosteatosis represent important prognostic factors in critically ill patients that can be easily obtained from routine CT scans. Both parameters at admission to the ICU yield important information on the patients' long-term outcome and might be used for early clinical decision-making in these patients.

Identifiants

pubmed: 32832910
doi: 10.1097/CCE.0000000000000171
pmc: PMC7418902
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0171

Informations de copyright

Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.

Références

Einstein (Sao Paulo). 2019 Aug 19;17(4):eAO4632
pubmed: 31433007
Am J Transplant. 2020 Feb;20(2):493-503
pubmed: 31448486
J Hepatol. 2019 Jan;70(1):172-193
pubmed: 30144956
J Cachexia Sarcopenia Muscle. 2010 Dec;1(2):147-157
pubmed: 21475702
Respir Care. 2020 Jul;65(7):1011-1018
pubmed: 32184374
Acta Physiol (Oxf). 2014 Mar;210(3):489-97
pubmed: 24393306
J Cachexia Sarcopenia Muscle. 2016 May;7(2):126-35
pubmed: 27493866
PLoS One. 2018 May 3;13(5):e0196235
pubmed: 29723245
Exp Physiol. 2013 Feb;98(2):359-71
pubmed: 22941979
Geriatr Gerontol Int. 2019 Sep;19(9):896-901
pubmed: 31309700
Magn Reson Imaging. 2012 Nov;30(9):1323-41
pubmed: 22770690
Liver Transpl. 2014 Jun;20(6):640-8
pubmed: 24678005
Nutrients. 2020 Jan 09;12(1):
pubmed: 31936597
J Am Med Dir Assoc. 2011 May;12(4):249-56
pubmed: 21527165
Abdom Radiol (NY). 2019 May;44(5):1907-1916
pubmed: 30694368
Arch Gerontol Geriatr. 2019 Jul - Aug;83:151-154
pubmed: 31029040
Surg Today. 2018 Feb;48(2):151-157
pubmed: 28699003
Liver Int. 2018 Oct;38(10):1706-1717
pubmed: 29738109
PLoS One. 2012;7(12):e51862
pubmed: 23251644
J Crit Care. 2018 Aug;46:50-54
pubmed: 29677586
Cancers (Basel). 2019 Oct 08;11(10):
pubmed: 31597337
Semin Musculoskelet Radiol. 2020 Apr;24(2):194-200
pubmed: 32438445
Eur Radiol. 2019 Sep;29(9):4709-4717
pubmed: 30689036
Crit Care. 2013 Sep 19;17(5):R206
pubmed: 24050662
J Cachexia Sarcopenia Muscle. 2011 Jun;2(2):111-117
pubmed: 21766057
J Hepatol. 2017 Jan;66(1):123-131
pubmed: 27599824
Eur J Clin Nutr. 2018 Feb;72(2):288-296
pubmed: 29242526
J Hepatol. 2017 Oct;67(4):749-757
pubmed: 28668580
Chest. 2019 Feb;155(2):322-330
pubmed: 30392790

Auteurs

Sven H Loosen (SH)

Department of Medicine III, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany.
Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Maximilian Schulze-Hagen (M)

Department of Diagnostic and Interventional Radiology, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany.

Tobias Püngel (T)

Department of Medicine III, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany.

Lukas Bündgens (L)

Department of Medicine III, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany.

Theresa Wirtz (T)

Department of Medicine III, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany.

Jakob N Kather (JN)

Department of Medicine III, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany.

Mihael Vucur (M)

Division of Gastroenterology, Hepatology and Hepatobiliary Oncology, University Hospital RWTH Aachen, Aachen, Germany.

Pia Paffenholz (P)

Department of Urology, University Hospital Cologne, Cologne, Germany.

Münevver Demir (M)

Department of Hepatology and Gastroenterology, Charité University Medicine Berlin, Berlin, Germany.

Philipp Bruners (P)

Department of Diagnostic and Interventional Radiology, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany.

Christiane Kuhl (C)

Department of Diagnostic and Interventional Radiology, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany.

Christian Trautwein (C)

Department of Medicine III, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany.

Frank Tacke (F)

Department of Hepatology and Gastroenterology, Charité University Medicine Berlin, Berlin, Germany.

Tom Luedde (T)

Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Division of Gastroenterology, Hepatology and Hepatobiliary Oncology, University Hospital RWTH Aachen, Aachen, Germany.

Alexander Koch (A)

Department of Medicine III, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany.

Christoph Roderburg (C)

Department of Hepatology and Gastroenterology, Charité University Medicine Berlin, Berlin, Germany.

Classifications MeSH